• News
  • SAN DIEGO
  • Finance

Merck Q4 net drops 14 pct. on generic competition

Merck & Co. reported a 14 percent decline in fourth-quarter profit as generic competition continued to cut into sales of one-time blockbuster medicines, and unfavorable currency exchange rates reduced overseas revenue.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!